Find clinical trials for Multiple Myeloma in Washington, DC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Washington, DC, USA:
lenalidomide, and dexamethasone (DRd) for first-line treatment of multiple myeloma (MM).FDA has approved selinexor plus dexamethaso ...
Phase 2
Columbia, Maryland, United States and 9 other locations
This is a phase II study to evaluate the outpatient administration of Teclistamab or Talquetamab in Multiple Myeloma patients...
Phase 2
Fairfax, Virginia, United States and 16 other locations
This is a phase 1, multicenter, open-label study evaluating the safety and efficacy of ruxolitinib, steroids and lenalidomide among MM patients who c...
Phase 1
Bethesda, Maryland, United States and 12 other locations
A Phase 2, open-label, dose escalation study to evaluate the safety and efficacy of venetoclax in combination with carfilzomib-dexamethasone (Kd) in...
Phase 2
Baltimore, Maryland, United States and 31 other locations
versus standard regimens in subjects with relapsed and refractory multiple myeloma (RRMM).The study is anticipated to randomize app...
Phase 3
Baltimore, Maryland, United States and 59 other locations
versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant (ASCT) in newly diagnosed multiple...
Phase 3
Baltimore, Maryland, United States and 107 other locations
Multiple Myeloma (MM) is a cancer of the blood's plasma cells ( blood cell). The cancer is typically found in the bones and bone ma...
Phase 1
Fairfax, Virginia, United States and 41 other locations
This is a Phase I/II, modular, open-label, multicenter, dose escalation, and dose expansion/optimization study to evaluate the safety, tolerability,...
Phase 1, Phase 2
Fairfax, Virginia, United States and 39 other locations
monotherapy (control) in participants with newly diagnosed multiple myeloma after undergoing autologous stem cell transplant. In Pa...
Phase 3
Washington D.C., District of Columbia, United States and 211 other locations
in combination with pomalidomide and dexamethasone, in patients with multiple myeloma that has come back following treatment and wh...
Phase 2
Bethesda, Maryland, United States and 10 other locations
Clinical trials
Research sites
Resources
Legal